Green fluorescent protein as a selectable marker of fibronectin-facilitated retroviral gene transfer in primary human T lymphocytes

Human Gene Therapy

Volumn 10, Issue 1, 1999, Pages 5-14

  Dardalhon, Valérie ^a   Noraz, Nelly ^a   Pollok, Karen ^b   Rebouissou, Cosette ^a   Boyer, Myriam ^a   Bakker, Arjen Q ^c   Spits, Hergen ^c   Taylor, Naomi ^a  

^a INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD28 ANTIGEN; FIBRONECTIN; GREEN FLUORESCENT PROTEIN; MONOCLONAL ANTIBODY CD3; PHYTOHEMAGGLUTININ;

ARTICLE; CONTROLLED STUDY; EXPRESSION VECTOR; GENETIC MARKER; GENETIC SELECTION; GENETIC TRANSDUCTION; GIBBON LEUKEMIA VIRUS; HUMAN; HUMAN CELL; RETROVIRUS; T LYMPHOCYTE;

CELL CYCLE; FIBRONECTINS; FLOW CYTOMETRY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; INDICATORS AND REAGENTS; JURKAT CELLS; LEUKEMIA VIRUS, GIBBON APE; LUMINESCENT PROTEINS; RETROVIRIDAE; T-LYMPHOCYTES; TRANSDUCTION, GENETIC;

EID: 0032958546     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950019147     Document Type: Article

References (43)

1. ANDREADIS, ST., BROTT, D., FULLER, A.O., and PALLSON, B.O. (1997). Moloney murine leukemia virus-derived retroviral vectors decay intracellularly with a half-life in the range of 5.5 to 7.5 hours. J. Virol. 71, 7541-7548.
2. BIERHUIZEN, M.F., WESTERMAN, Y., VISSER, T.P., DIMJATI, W., WOGNUM, A.W., and WAGEMAKER, G. (1997). Enhanced green fluorescent protein as selectable marker of retroviral-mediated gene transfer in immature hematopoietic bone marrow cells. Blood 90, 3304-3315.
3. BRAUN, S.E., PAN, D., ARONOVICH, E.L., JONSSON, J.J., McIVOR, R.S., and WHITLEY, C.B. (1996). Preclinical studies of lymphocyte gene therapy for mild Hunter syndrome (mucopolysaccharidosis type II). Hum. Gene Ther. 7, 283-290.
4. BUNNELL, B.A., MUUL, L.M., DONAHUE, R.E., BLAESE, R.M., and MORGAN, R.A. (1995). High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 92, 7739-7743.
5. CHENG, L., FU, J., TSUKAMOTO, A., and HAWLEY, R.G. (1996). Use of green fluorescent protein variants to monitor gene transfer and expression in mammalian cells. Nature Biotechnol. 14, 606.
6. CORMACK, B.P., VALDIVIA, R.H., and FALKOW, S. (1996). FACS-optimized mutants of the green fluorescent protein (EGFP). Gene 173, 33-38.
7. DUNBAR, C.E., COTTLER, F.M., O'SHAUGHNESSY, J.A., DOREN, S., CARTER, C., BERENSON, R., BROWN, S., MOEN, R.C., GREENBLATT, J., and STEWART, F.M. (1995). Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood 85, 3048-3057.
8. FRIBERG, D., BRYANT, J., SHANNON, W., and WHITESIDE, T.L. (1994). In vitro cytokine production by normal human peripheral blood mononuclear cells as a measure of immunocompetence or the state of activation. Clin. Diagn. Lab. Immunol. 1, 261-268.
9. HANAZONO, Y., YU, J.M., DUNBAR, C.E., and EMMONS, R.V. (1997). Green fluorescent protein retroviral vectors: Low titer and high recombination frequency suggest a selective disadvantage. Hum. Gene Ther. 8, 1313-1319.
10. HANENBERG, H., XIAO, X.L., DILLOO, D., HASHING, K., KATO, I., and WILLIAMS, D.A. (1996). Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells. Nature Med. 2, 876-882.
11. HEEMSKERK, M.H., BLOM, B., NOLAN, G., STEGMANN, A.P., BAKKER, A.Q., WEIJER, K., RES, P.C., and SPITS, H. (1997). Inhibition of T cell and promotion of natural killer cell development by the dominant negative helix loop helix factor Id3. J. Exp. Med. 186, 1597-1602.
12. KELLER, G., PAIGE, C., GILBOA, E., and WAGNER, E.F. (1985). Expression of a foreign gene in myeloid and lymphoid cells derived from multipotent haematopoietic precursors. Nature (London) 318, 149-154.
13. KIMIZUKA, F., TAGUCHI, Y., OHDATE, Y., KAWASE, T., SHIMOJO, K., HASHIO, I., KATO, I., SEKIGUCHI, K., and TITANI, K. (1991). Production and characterization of functional domains of human fibronectin expressed in Escherichia coli. J. Biochem. 110, 284-291.
14. KINSELLA, T.M., and NOLAN, G.P. (1996). Episomal vectors rapidly and stably produce high-liter recombinant rectovirus. Hum. Gene Ther. 7, 1405-1413.
15. KLEIN, D., INDRACCOLO, S., VON ROMBS, K., AMADORI, A., SALMONS, B., and GUNZBERG, W.H. (1997). Rapid identification of viable retrovirus-transduced cells using the green fluorescent protein as a marker. Gene Ther. 4, 1256-1260.
16. KOHN, D.B., WEINBERG, K.I., NOLTA, J.A., HEISS, L.N., LENARSKY, C., CROOKS, G.M., HANLEY, M.E., ANNETT, G., BROOKS, J.S., EL-KHOUREIY, A., LAWRENCE, K., WELLS, S., MOEN, R.C., et al. (1995). Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nature Med. 1, 1017-1023.
17. KUGA, T., SAKAMAKI, S., MATSUNAGA, T., HIRAYAMA, Y., KURODA, H., TAKAHASHI, Y., KUSAKABE, T., KATO. I., and NIITSU, Y. (1997). Fibronectin fragment-facilitated retroviral transfer of the glutathione-S-transferase pi gene into CD34+ cells to protect them against alkylating agents. Hum. Gene Ther. 8, 1901-1910.
18. LAM, J.S., REEVES, M.E., COWHERD, R., ROSENBERG, S.A., and HWU, P. (1996). Improved gene transfer into human lymphocytes using retroviruses with the gibbon ape leukemia virus envelope. Hum. Gene Ther. 7, 1415-1422.
19. LEVY, J.P., MULDOON, R.R., ZOLOTUKHIN, S., and LINK, C. (1996). Retroviral transfer and expression of a humanized, red shifted green fluorescent protein gene into human tumor cells. Nature Biotechnol. 14, 610-614.
20. LEWIS, P.F., and EMERMAN, M. (1994). Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J. Virol. 68, 510-516.
21. LIMÓN, A., BRIONES, J., PUIG, T., CARMONA, M., FORNAS, O., CANCELAS, J.A., NADAL, M., GARCIA, J., RUEDA, F., and BARQUINERO, J. (1997). High-liter retroviral vectors containing the enhanced green fluorescent protein gene for efficient expression in hematopoietic cells. Blood 90, 3316-3321.
22. LYNCH, C.M., and MILLER, A.D. (1991). Production of high-liter helper virus-free retroviral vectors by cocultivation of packaging cells with different host ranges. J. Virol. 65, 3887-3890.
23. MACNEILL, E.C., HANENBERG, H., BIERHUIZEN, M., WAGEMAKER, G., and WILLIAMS, D.A. (1998). Blocking retroviral receptors by amphotropic pseudotyped virus renders target cells less susceplible to subsequent infection with vectors of the same interference group for up to 24 hours. American Society of Gene Therapy, Seattle, May 1998, abstract 78.
24. MARKOWITZ, D., GOFF, S., and BANK, A. (1988). A safe packaging line for gene transfer: Separating genes on two different plasmids. J. Virol. 62, 1120-1124.
25. MAVILIO, F., FERRARI, G., ROSSINI, S., NOBILI, N., BONINI, C., CASORATI, G., TRAVERSARI, C., and BORDIGNON, C. (1994). Peripheral blood lymphocytes as target cells of retroviral vector-mediated gene transfer. Blood 83, 1988-1997.
26. MILLER, A.D., GARCIA, J.V., VON, S.N., LYNCH, C.M., WILSON, C., and EIDEN, M.V. (1991). Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J. Virol. 65, 2220-2224.
27. MILLER, D.G., ADAM, M.A., and MILLER, A.D. (1990). Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol. Cell. Biol. 10, 4239-4242.
28. MORITZ, T., PATEL, V.P., and WILLIAMS, D.A. (1994). Bone marrow extracellular matrix molecules improve gene transfer into human hematopoietic cells via retroviral vectors. J. Clin. Invest. 93, 1451-1457.
29. NOLAN, G.P., FIERING, S., NICOLAS, J.F., and HERZENBERG, L.A. (1988) Fluorescence-activated cell analysis and sorting of viable mammalian cells based on beta-D-galactosidase activity after transduction of Escherichia coli lacZ. Proc. Natl. Acad. Sci. U.S.A. 85, 2603-2607.
30. PERSONS, D.A., ALLAY, J.A., ALLAY, E.R., SMEYNE, R.J., ASHMUN, R.A., SORRENTINO, B.P., and NIENHUIS, A.W. (1997). Retroviral-mediated transfer of the green fluorescent protein gene into murine hematopoietic cells facilitates scoring and selection of transduced progenitors in vitro and identification of genetically modified cells in vivo. Blood 90, 1777-1786.
31. POLLOK, K.E., HANENBERG, H., NOBLITT, T.W., SCHRODER, W.L., KATO, I., EMANUEL, D., and WILLIAMS, D.A. (1998). High-efficiency gene transfer into normal and adenosine deaminase-deficient T lymphocytes is mediated by transduction on recombinant fibronectin fragments. J. Virol. 72, 4882-4892.
32. RAMIRO, A.R., DE YEBENES, V.O., TRIGUEROS, C., CARRASCO, Y.R., and TORIBIO, M.L. (1998). Enhanced green fluorescent protein as an efficient reporter gene for retroviral transduction of human multipotent lymphoid precursors. Hum. Gene Ther. 9, 1103-1109.
33. RASKO, J.E.J., KIEM, H.-P., MORRIS, J.C., GOTTSCHALK, R.J., PETERSON, L.J., ANDREWS, R.G., and MILLER, A.D. (1997). Efficient transduction of hematopoietic progenitors using green fluorescent protein (GFP)-containing retroviral vectors with various pseudotypes. Blood 90, 514. [Abstract]
34. ROE, T., REYNOLDS, T.C., YU, G., and BROWN, P.O. (1993). Integration of murine leukemia virus DNA depends on mitosis. EMBO J. 12, 2099-2108.
35. RUDOLL, T., PHILLIPS, K., LEE, S.W., HULL, S., GASPAR, O., SUCGANG, N., GILBOA, E., and SMITH, C. (1996). High-efficiency retroviral vector mediated gene transfer into human peripheral blood CD4+ T lymphocytes. Gene Ther. 3, 695-705.
36. SHIMIZU, Y., VAN SEVENTER, G.A., ENNIS, E., NEWMAN, W., HORGAN, K.J., and SHAW, S. (1992). Crosslinking of the T cell-specific accessory molecules CD7 and CD28 modulates T cell adhesion. J. Exp. Med. 175, 577-582.
37. STAAL, F.J., BAKKER, A.Q., VERKUYLEN, M., VAN OORT, E., and SPITS, H. (1996). Use of bicistronic retroviral vectors encoding the LacZ gene together with a gene of interest: A method to select producer cells and follow transduced target cells. Cancer Gene Ther. 3, 345-351.
38. STRAIR, R.K., TOWLE, M., and SMITH, B.R. (1990). Retroviral mediated gene transfer into bone marrow progenitor cells: Use of beta-galactosidase as a selectable marker. Nucleic Acids Res. 18, 4759-4762.
39. VIEILLARD, V., LAURET, E., ROUSSEAU, V., and DE, M.E. (1994). Blocking of retroviral infection at a step prior to reverse transcription in cells transformed to constitutively express interferon beta. Proc. Natl. Acad. Sci. U.S.A. 91, 2689-2693.
40. WOFFENDIN, C., YANG, Z.Y., UDAYKUMAR, XU, L., YANG, N.S., SHEEHY, M.J., and NABEL, G.J. (1994). Nonviral and viral delivery of a human immunodeficiency virus protective gene into primary human T cells. Proc. Natl. Acad. Sci. U.S.A. 91, 11581-11585.
41. YANG, T.T., CHENG, L., and KAIN, S.R. (1996). Optimized codon usage and chromophore mutations provide enhanced sensitivity with the green fluorescent protein. Nucleic Acids Res. 24, 4592-4593.
42. YSSEL, H., DE, V.J., KOKEN, M., VAN, B.W., and SPITS, H. (1984). Serum-free medium for generation and propagation of functional human cytotoxic and helper T cell clones. J. Immunol. Methods 72, 219-227.
43. ZHANG, G., GURTU, V., and KAIN, S.R. (1996). An enhanced green fluorescent protein allows sensitive detection of gene transfer in mammalian cells. Biochem. Biophys. Res. Commun. 227, 707-711.